The Latest Breaking News from FDA

The pharmaceutical industry is experiencing rapid growth thanks to healthcare demand, regulatory initiatives, and technological adoption in drug discovery and development. Hence, it could be wise to invest in pharma stocks Ipsen (IPSEY), Bristol-Myers (BMY), and Taro Pharmaceutical (TARO) to drive your bottom line. These stocks are rated A (Strong…

The pharma industry’s resilience and long-term prospects are driven by rising healthcare demand, an enhanced focus on precision medicines, and technological advancements. Hence, let’s take a look at pharma stocks Perrigo Company (PRGO), Amneal Pharmaceuticals (AMRX), and Supernus Pharmaceuticals (SUPN), which could diversify your investments. Read on….

ShivamoggaHassan Deputy Commissioner suspends official for forwarding political message on WhatsApp, violating model code of conduct.

Exclusive-Synchron's FDA-approved brain implant trial showcases advancements in brain-computer interface technology, shaping the future of neurotechnology.

The government still blames the private sector despite its own role in creating, exacerbating, and prolonging the shortage.

FDA warns against selling ZYN nicotine pouches to minors, emphasizing risks of nicotine addiction and underage tobacco use.

Amylyx Pharmaceuticals withdraws Relyvrio drug for ALS due to lack of efficacy, leading to layoffs and disappointment in ALS community.

A human case of avian influenza in Texas this week has prompted Congress to gather information about risks to public health and agriculture.

Bird flu in cows and goats has raised alarm in the U.S. To date, four people are thought to have caught the virus from cattle, but the risk to the general public is low.